Researchers at the University of Tennessee Health Science Center have played a supporting role in the development of COVID-19 vaccines. To examine the efficacy of the Pfizer-BioNTech vaccine during development, the company needed a way to test the inhibitory effects of the antibodies generated after vaccination on virus infection. However, to work with SARS-CoV-2 requires… Read More
Shaunah Ritter, DO, an allergy and immunology Fellow at Le Bonheur Children’s Hospital, was the first person to receive the COVID-19 vaccine Saturday morning, as the University of Tennessee Health Science Center began administering it to residents, students on hospital rotations, campus first responders, and faculty who provide inpatient services. “I honestly had trouble sleeping… Read More
Centers for Disease Control and Prevention Director Robert Redfield, MD, said the next few months of the pandemic will be probably the worst in the history of public health in the United States. However, vaccines on the horizon provide a “light at the end of the tunnel” in the battle against COVID-19. During a… Read More
The academic productivity of higher education faculty In the United States in the science, technology, engineering, mathematics, and medicine (STEMM) fields with very young children suffered as a result of the stay-at-home orders during the early months of the coronavirus pandemic, according to a new study by researchers at the University of Tennessee Health Science… Read More
In his 2019-2020 State of the University Address, Chancellor Steve J. Schwab, MD, Monday said the University of Tennessee Health Science Center is “weathering COVID in a lean, but strong fashion.” Speaking via Zoom in his 11th-annual State of the University Address, the chancellor said the university has “maintained our budget, maintained our workforce, and… Read More
The University of Tennessee Health Science Center and Regional One Health have established a post-COVID-19 clinic to provide specialized outpatient follow-up care to individuals who have tested positive for the virus and may be experiencing long-term symptoms after recovery. The clinic will also be available to individuals who have tested positive for COVID-19 and are… Read More
Researchers at the University of Tennessee Health Science Center working with colleagues at the University of New Mexico have identified three drugs, already approved for other uses in humans, as possible therapeutics for COVID-19, the illness caused by the SARS-CoV-2 virus. Based on virtual and in vitro antiviral screening that began in the earlier months of… Read More
The University of Tennessee Health Science Center and Regional One Health today are announcing that they are partnering on a clinical trial program including two late-stage clinical trials evaluating Regeneron’s REGN-COV2, the company’s investigational two-antibody cocktail for the treatment and prevention of COVID-19. Leading the efforts are John Jefferies, MD, MPH, FAAP, FACC, FAHA, FHFSA,… Read More
